CTOs on the Move

Obstetrix Medical Group

www.obstetrix.com

 
Obstetrix Medical Group is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.obstetrix.com
  • 900 E Hamilton Ave Ste 220
    Campbell, CA USA 95008
  • Phone: 408.371.7111

Executives

Name Title Contact Details

Similar Companies

ProCare Rx

ProCare Rx is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Image Owl

Image Owl creates complete, convenient , accurate and insightful cloud-based solutions to analyze and manage your diagnostic medical imaging and radiotherapy quality assurance needs.

American Addiction Centers

Why American Addiction Centers? We take a big picture approach to addiction recovery treatment – addressing the individual`s whole lifestyle in relation to substance use, alcohol and binge eating addiction and partnering with the family throughout the treatment process whenever possible. With our research-based programs, our inpatient treatment centers don`t just focus on the problem; we strengthen the individual and focus on the future. Whether it`s the initial clinical assessments, medically supervised detox, residential rehabilitation or aftercare, our team is present for and committed to each step of the recovery process for every individual. American Addiction Centers is an equal opportunity and drug free employer. All decisions regarding recruiting and hiring will be made without unlawful discrimination on the basis of race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, or age.

Scryptions International

Scryptions International is a Henderson, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.